Structure and topology of monomeric phospholamban in lipid membranes determined by a hybrid solution and solid-state NMR approach - PubMed (original) (raw)
Structure and topology of monomeric phospholamban in lipid membranes determined by a hybrid solution and solid-state NMR approach
Nathaniel J Traaseth et al. Proc Natl Acad Sci U S A. 2009.
Abstract
Phospholamban (PLN) is an essential regulator of cardiac muscle contractility. The homopentameric assembly of PLN is the reservoir for active monomers that, upon deoligomerization form 1:1 complexes with the sarco(endo)plasmic reticulum Ca(2+)-ATPase (SERCA), thus modulating the rate of calcium uptake. In lipid bilayers and micelles, monomeric PLN exists in equilibrium between a bent (or resting) T state and a more dynamic (or active) R state. Here, we report the high-resolution structure and topology of the T state of a monomeric PLN mutant in lipid bilayers, using a hybrid of solution and solid-state NMR restraints together with molecular dynamics simulations in explicit lipid environments. Unlike the previous structural ensemble determined in micelles, this approach gives a complete picture of the PLN monomer structure in a lipid bilayer. This hybrid ensemble exemplifies the tilt, rotation, and depth of membrane insertion, revealing the interaction with the lipids for all protein domains. The N-terminal amphipathic helical domain Ia (residues 1-16) rests on the surface of the lipid membrane with the hydrophobic face of domain Ia embedded in the membrane bilayer interior. The helix comprised of domain Ib (residues 23-30) and transmembrane domain II (residues 31-52) traverses the bilayer with a tilt angle of approximately 24 degrees . The specific interactions between PLN and lipid membranes may represent an additional regulatory element of its inhibitory function. We propose this hybrid method for the simultaneous determination of structure and topology for membrane proteins with compact folds or proteins whose spatial arrangement is dictated by their specific interactions with lipid bilayers.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
Fig. 1.
Solid-state NMR spectra of AFA-PLN in lipid bilayers. (A) Primary sequence of AFA-PLN showing assigned residues in gray (CSA and DC assignments in
Table S1
). (B) Assigned PISEMA (Leu, Ala) and SAMPI4 spectra (Ser, Arg) of domain Ia. (C) [U-15N] PISEMA spectrum of PLN domain Ib and II displaying a uniform intensity across the PISA wheel. (D) Selectively labeled PLN PISEMA spectra of domain Ib and II. Overlay shown in
Fig. S3
.
Fig. 2.
Experimental CSA (A) and DC (C) values from Fig. 1 plotted vs. residue number. (B and D) show correlation plots of calculated vs. experimental CSA and DC for the hybrid ensemble, respectively. The parallel lines in B and D indicate the experimental errors used in the structural calculations.
Fig. 3.
Comparison between the solution NMR ensemble and the conformational ensemble generated with the hybrid protocol. (A) Angles used to describe the topology of monomeric AFA-PLN. (B) Rotation (ρ) versus tilt angle (θ) for the 20 structures in the deposited ensemble. The _Inset_s better allow for variations to be seen in the angles describing the topology with respect to the membrane normal for domains Ib and II (Left, circles) and domain Ia (Right, triangles). (C) Comparison of the ensemble of structures generated from solution NMR restraints alone (squares) with the hybrid solution and solid-state NMR method (circles).
Fig. 4.
Structural topology of monomeric PLN in a DOPC lipid bilayer. (A) Probability distribution profile for the chemical groups of DOPC in the molecular dynamics simulation of PLN within the bilayer. (B) Structure of monomeric AFA-PLN in a DOPC lipid bilayer. (C) Detailed images of the residues within the amphipathic domain Ia helix show that the hydrophobic residues (Val-4, Leu-7, Ala-11, Ile-12, Ala-15) face the interior of the bilayer. (D) Structure highlighting the face of PLN within domains Ib and II that have been shown by mutagenesis and cross-linking data to interact with SERCA (56). Residues in D shown with side chains in sticks and labeled on the structure reside on the same helix of PLN, i.e., they are positioned for binding SERCA. In both B and D, the colors reflect the hydrophobicity: light gray, hydrophobic; blue/red/purple, hydrophilic; green, aromatic (Phe); specifically Ser and Thr residues are shown in purple, Glu is shown in red, and Asn and Gln are shown in blue.
Similar articles
- Structural topology of phospholamban pentamer in lipid bilayers by a hybrid solution and solid-state NMR method.
Verardi R, Shi L, Traaseth NJ, Walsh N, Veglia G. Verardi R, et al. Proc Natl Acad Sci U S A. 2011 May 31;108(22):9101-6. doi: 10.1073/pnas.1016535108. Epub 2011 May 16. Proc Natl Acad Sci U S A. 2011. PMID: 21576492 Free PMC article. - Structural dynamics and topology of phospholamban in oriented lipid bilayers using multidimensional solid-state NMR.
Traaseth NJ, Buffy JJ, Zamoon J, Veglia G. Traaseth NJ, et al. Biochemistry. 2006 Nov 21;45(46):13827-34. doi: 10.1021/bi0607610. Biochemistry. 2006. PMID: 17105201 - Effects of naturally occurring arginine 14 deletion on phospholamban conformational dynamics and membrane interactions.
Vostrikov VV, Soller KJ, Ha KN, Gopinath T, Veglia G. Vostrikov VV, et al. Biochim Biophys Acta. 2015 Jan;1848(1 Pt B):315-22. doi: 10.1016/j.bbamem.2014.09.007. Epub 2014 Sep 22. Biochim Biophys Acta. 2015. PMID: 25251363 Free PMC article. - Solid-State NMR of Membrane Proteins in Lipid Bilayers: To Spin or Not To Spin?
Gopinath T, Weber D, Wang S, Larsen E, Veglia G. Gopinath T, et al. Acc Chem Res. 2021 Mar 16;54(6):1430-1439. doi: 10.1021/acs.accounts.0c00670. Epub 2021 Mar 3. Acc Chem Res. 2021. PMID: 33655754 Free PMC article. Review. - Structural and dynamic basis of phospholamban and sarcolipin inhibition of Ca(2+)-ATPase.
Traaseth NJ, Ha KN, Verardi R, Shi L, Buffy JJ, Masterson LR, Veglia G. Traaseth NJ, et al. Biochemistry. 2008 Jan 8;47(1):3-13. doi: 10.1021/bi701668v. Epub 2007 Dec 15. Biochemistry. 2008. PMID: 18081313 Free PMC article. Review.
Cited by
- Pathological mutations in the phospholamban cytoplasmic region affect its topology and dynamics modulating the extent of SERCA inhibition.
Weber DK, Reddy UV, Robia SL, Veglia G. Weber DK, et al. Biochim Biophys Acta Biomembr. 2024 Oct;1866(7):184370. doi: 10.1016/j.bbamem.2024.184370. Epub 2024 Jul 8. Biochim Biophys Acta Biomembr. 2024. PMID: 38986894 - Protein Design: From the Aspect of Water Solubility and Stability.
Qing R, Hao S, Smorodina E, Jin D, Zalevsky A, Zhang S. Qing R, et al. Chem Rev. 2022 Sep 28;122(18):14085-14179. doi: 10.1021/acs.chemrev.1c00757. Epub 2022 Aug 3. Chem Rev. 2022. PMID: 35921495 Free PMC article. Review. - Structures of PKA-phospholamban complexes reveal a mechanism of familial dilated cardiomyopathy.
Qin J, Zhang J, Lin L, Haji-Ghassemi O, Lin Z, Woycechowsky KJ, Van Petegem F, Zhang Y, Yuchi Z. Qin J, et al. Elife. 2022 Mar 17;11:e75346. doi: 10.7554/eLife.75346. Elife. 2022. PMID: 35297759 Free PMC article. - Towards a native environment: structure and function of membrane proteins in lipid bilayers by NMR.
Xue K, Movellan KT, Zhang XC, Najbauer EE, Forster MC, Becker S, Andreas LB. Xue K, et al. Chem Sci. 2021 Sep 7;12(43):14332-14342. doi: 10.1039/d1sc02813h. eCollection 2021 Nov 10. Chem Sci. 2021. PMID: 34880983 Free PMC article. Review. - A kink in DWORF helical structure controls the activation of the sarcoplasmic reticulum Ca2+-ATPase.
Reddy UV, Weber DK, Wang S, Larsen EK, Gopinath T, De Simone A, Robia S, Veglia G. Reddy UV, et al. Structure. 2022 Mar 3;30(3):360-370.e6. doi: 10.1016/j.str.2021.11.003. Epub 2021 Dec 6. Structure. 2022. PMID: 34875216 Free PMC article.
References
- von Heijne G. Membrane-protein topology. Nat Rev Mol Cell Biol. 2006;7:909–918. - PubMed
- Tada M, Kirchberger MA, Katz AM. Phosphorylation of a 22,000-dalton component of the cardiac sarcoplasmic reticulum by adenosine 3′:5′-monophosphate-dependent protein kinase. J Biol Chem. 1975;250:2640–2647. - PubMed
- Hoshijima M, et al. Chronic suppression of heart-failure progression by a pseudophosphorylated mutant of phospholamban via in vivo cardiac rAAV gene delivery. Nat Med. 2002;8:864–871. - PubMed
- Kaye DM, et al. Percutaneous cardiac recirculation-mediated gene transfer of an inhibitory phospholamban peptide reverses advanced heart failure in large animals. J Am Coll Cardiol. 2007;50:253–260. - PubMed
- Simmerman HK, Jones LR. Phospholamban: Protein structure, mechanism of action, and role in cardiac function. Physiol Rev. 1998;78:921–947. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- K02 HL080081-05/HL/NHLBI NIH HHS/United States
- R01 GM064742-08/GM/NIGMS NIH HHS/United States
- GM072701/GM/NIGMS NIH HHS/United States
- GM64742/GM/NIGMS NIH HHS/United States
- R01 GM064742/GM/NIGMS NIH HHS/United States
- K02 HL080081/HL/NHLBI NIH HHS/United States
- R01 GM072701/GM/NIGMS NIH HHS/United States
- HL80081/HL/NHLBI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous